Susunan keanggotaan Komite Nasional

Susunan keanggotaan Komite Nasional Penyusunan
Formularium Nasional, yang selanjutnya disebut
Komite sebagaimana tercantum dalam Lampiran yang
merupakan bagian tidak terpisahkan dari Keputusan
Menteri ini.
KEDUA : Komite sebagaimana dimaksud dalam Diktum Kesatu
terdiri dari Tim Ahli, Tim Evaluasi, dan Tim Pelaksana
yang masing-masing bertugas:
1. Tim Ahli bertugas:
a. memberikan masukan teknis/ilmiah dalam
penyusunan Formularium Nasional; dan
KEPUTUSAN MENTERI KESEHATAN RI
179
165
b. melakukan penilaian terhadap usulan obat
yang akan dimasukkan dalam Formularium
Nasional.
2. Tim Evaluasi bertugas:
a. melakukan evaluasi daftar obat dalam
Formularium Nasional; dan
b. memberikan dukungan teknis dalam
penerapan kebijakan Formularium Nasional
yang telah ditetapkan.
3. Tim Pelaksana bertugas:
a. menyusun daftar obat yang akan dimasukkan
dalam Formularium Nasional;
b. menginventarisasi dan mengompilasi usulan
masukan daftar obat yang akan dimasukkan
dalam Formularium Nasional;
c. menyiapkan rancangan Formularium Nasional;
dan
d. melaksanakan pendokumentasian, finalisasi
dan pelaporan kegiatan penyusunan
Formularium Nasional.
4. Tim Review bertugas:
a. menyusun kajian evaluasi efikasi dan
keamanan obat dengan meminta
pertimbangan tim ahli farmakologi dan
epidemiologi klinik; dan
b. memberikan masukkan teknis/ilmiah yang di
perlukan Tim Evaluasi.
KETIGA : Tugas Komite sebagaimana dimaksud dalam Diktum
Kedua mulai berlaku pada bulan Januari sampai
dengan Desember tahun 2015, kecuali tugas Tim
Evaluasi sampai dengan Desember tahun 2016.
KEEMPAT : Dalam melaksanakan tugasnya Komite bertanggung
jawab dan menyampaikan laporan paling lambat 1
(satu) bulan setelah berakhir masa tugas kepada
Menteri Kesehatan melalui Direktur Jenderal yang
tugas dan fungsinya di bidang Kefarmasian dan Alat
Kesehatan.
KELIMA : Segala pembiayaan yang timbul atas pelaksanaan
tugas Komite dibebankan pada DIPA Direktorat Bina
Pelayanan Kefarmasian Tahun 2015.
KEENAM : Pada saat Keputusan Menteri ini berlaku, Keputusan
Menteri Kesehatan Nomor 228/Menkes/SK/VI/2013
tentang Komite Nasional Penyusunan Formularium
Nasional 2013 dicabut, dan dinyatakan tidak berlaku.
KEPUTUSAN MENTERI KESEHATAN RI
180
166
KEENAM : Keputusan Menteri ini mulai berlaku pada tanggal
ditetapkan.
Ditetapkan di Jakarta
pada tanggal 7 April 2015
MENTERI KESEHATAN
REPUBLIK INDONESIA,
T.t.d
NILA FARID MOELOEK
165
b. melakukan penilaian terhadap usulan obat
yang akan dimasukkan dalam Formularium
Nasional.
2. Tim Evaluasi bertugas:
a. melakukan evaluasi daftar obat dalam
Formularium Nasional; dan
b. memberikan dukungan teknis dalam
penerapan kebijakan Formularium Nasional
yang telah ditetapkan.
3. Tim Pelaksana bertugas:
a. menyusun daftar obat yang akan dimasukkan
dalam Formularium Nasional;
b. menginventarisasi dan mengompilasi usulan
masukan daftar obat yang akan dimasukkan
dalam Formularium Nasional;
c. menyiapkan rancangan Formularium Nasional;
dan
d. melaksanakan pendokumentasian, finalisasi
dan pelaporan kegiatan penyusunan
Formularium Nasional.
4. Tim Review bertugas:
a. menyusun kajian evaluasi efikasi dan
keamanan obat dengan meminta
pertimbangan tim ahli farmakologi dan
epidemiologi klinik; dan
b. memberikan masukkan teknis/ilmiah yang di
perlukan Tim Evaluasi.
KETIGA : Tugas Komite sebagaimana dimaksud dalam Diktum
Kedua mulai berlaku pada bulan Januari sampai
dengan Desember tahun 2015, kecuali tugas Tim
Evaluasi sampai dengan Desember tahun 2016.
KEEMPAT : Dalam melaksanakan tugasnya Komite bertanggung
jawab dan menyampaikan laporan paling lambat 1
(satu) bulan setelah berakhir masa tugas kepada
Menteri Kesehatan melalui Direktur Jenderal yang
tugas dan fungsinya di bidang Kefarmasian dan Alat
Kesehatan.
KELIMA : Segala pembiayaan yang timbul atas pelaksanaan
tugas Komite dibebankan pada DIPA Direktorat Bina
Pelayanan Kefarmasian Tahun 2015.
KEENAM : Pada saat Keputusan Menteri ini berlaku, Keputusan
Menteri Kesehatan Nomor 228/Menkes/SK/VI/2013
tentang Komite Nasional Penyusunan Formularium
Nasional 2013 dicabut, dan dinyatakan tidak berlaku.
166
KEENAM : Keputusan Menteri ini mulai berlaku pada tanggal
ditetapkan

結果 (英語) 1:

The arrangement Drafting National Committee membershipFormularium national, hereinafter referredOf the Committee as contained in the AnnexIt is part an integral part of the decisionThis Minister.Secondly, the Committee referred to in the one Dictumconsists of a team of experts, the evaluation team, and Managing Teameach serving:1. the team of experts in charge of:a. scientific/technical input in thedrafting National Formularium; andTHE DECISION OF THE MINISTER OF HEALTH RI179165b. conducting assessment of proposed remedyto be included in FormulariumNationwide.2. the evaluation team is in charge of:a. conducting evaluation in drug listFormularium National; andb. provide technical support in thethe application of the policy of National Formulariumthat has been established.3. The implementing Team in charge:a. compiled a list of drugs that will be includedin National Formularium;b. inventory and compile proposalinput a list of drugs that will be includedin National Formularium;c. prepare a draft National Formularium;andd. carry out documentation, finalizationand reporting activities of the preparationFormularium Nationwide.4. The Review team on duty:a. Drawing up studies and efficacy evaluationdrug safety by askingconsideration of the expert team of Pharmacology andClinical Epidemiology; andb. provide technical/scientific enter inneed the team evaluation.Third: the task of the Committee as intended in the DictumBoth entered into force in January untilby December 2015, unless the Task TeamEvaluation until December 2016.FOURTH: in doing their job the Committee responsibleresponsibility and submit a report no later than 1(one) month after the end time of the task toMinister of health through the Director General of thethe tasks and functions in the field of Kefarmasian and toolsHealth.Fifth: All financing arising upon the exercise ofthe task of the Committee charged to Community Development Directorate DIPAKefarmasian services by 2015.SIXTH: at the time of the decision of the Minister is valid, the decisionThe Minister of health the number 228/Menkes/SK/VI/2013about the National Committee for the preparation of FormulariumNational 2013 revoked, and be declared not applicable.THE DECISION OF THE MINISTER OF HEALTH RI180166SIXTH: this Minister's decision comes into force on the date ofset.Established in Jakartaon April 7, 2015THE MINISTER OF HEALTHTHE REPUBLIC OF INDONESIA,T.t. dINDIGO FARID MOELOEK165b. conducting assessment of proposed remedyto be included in FormulariumNationwide.2. the evaluation team is in charge of:a. conducting evaluation in drug listFormularium National; andb. provide technical support in thethe application of the policy of National Formulariumthat has been established.3. The implementing Team in charge:a. compiled a list of drugs that will be includedin National Formularium;b. inventory and compile proposalinput a list of drugs that will be includedin National Formularium;c. prepare a draft National Formularium;andd. carry out documentation, finalizationand reporting activities of the preparationFormularium Nationwide.4. The Review team on duty:a. Drawing up studies and efficacy evaluationdrug safety by askingconsideration of the expert team of Pharmacology andClinical Epidemiology; andb. provide technical/scientific enter inneed the team evaluation.Third: the task of the Committee as intended in the DictumBoth entered into force in January untilby December 2015, unless the Task TeamEvaluation until December 2016.FOURTH: in doing their job the Committee responsibleresponsibility and submit a report no later than 1(one) month after the end time of the task toMinister of health through the Director General of thethe tasks and functions in the field of Kefarmasian and toolsHealth.Fifth: All financing arising upon the exercise ofthe task of the Committee charged to Community Development Directorate DIPAKefarmasian services by 2015.SIXTH: at the time of the decision of the Minister is valid, the decisionThe Minister of health the number 228/Menkes/SK/VI/2013about the National Committee for the preparation of FormulariumNational 2013 revoked, and be declared not applicable.166SIXTH: this Minister's decision comes into force on the date ofset

結果 (英語) 2:

The composition of the membership of the National Committee for Drafting
formulary, National, hereinafter called
the Committee as contained in the Appendix which
is an integral part of the Decree
of the Minister.
SECOND: The Committee referred to in Dictum One
consists of the Expert Team, Team Evaluation and Implementation Team
that each duty :
1. Expert Team tasked to:
a. to provide the technical / scientific
preparation of the National Formulary; and
THE MINISTER OF HEALTH RI
179
165
b. assessing the drug's proposal
to be included in the formulary,
National.
2. The evaluation team is tasked to:
a. evaluating the list of drugs in the
formulary, the National; and
b. provide technical support in
the implementation of the National Formulary policies
that have been established.
3. Implementation Team tasked to:
a. compile a list of drugs that will be included
in the National Formulary;
b. inventory and compile proposals
enter the list of drugs that will be included
in the National Formulary;
c. prepare a draft National Formulary;
and
d. carry out documentation, finalization
and reporting drafting
Formulary National.
4. The Review Team tasked to:
a. preparing a study evaluating the efficacy and
safety of drugs by asking for
consideration of the expert team of pharmacology and
clinical epidemiology; and
b. provide technical insert / scientific in
need evaluation team.
THIRD: The task of the Committee referred to in Dictum
Both came into force on January to
December 2015, except for the task team
evaluation until December 2016.
FOURTH: In the work of the Committee shall be
responsible and submit a report no later than 1
(one) month after the termination of their assignment to
the Minister of Health through the Director General of the
tasks and functions in the field of Pharmaceutical and Equipment
Health.
FIFTH: Any financing arising from the implementation of
the Committee's tasks charged to DIPA Directorate of
Pharmaceutical Services in 2015.
SIXTH: at the time of this decree, Decree
of the Minister of Health No. 228 / Menkes / SK / VI / 2013
of the National Committee for Drafting Formulary
National 2013 revoked and declared no longer valid.
MINISTER oF HEALTH RI
180
166
SIXTH: this decree comes into force on the date of
enactment.
Enacted in Jakarta
on 7 April 2015
tHE MINISTER OF HEALTH
OF tHE REPUBLIC OF INDONESIA,
signed
INDIGO FARID MOELOEK
165
b. assessing the drug's proposal
to be included in the formulary,
National.
2. The evaluation team is tasked to:
a. evaluating the list of drugs in the
formulary, the National; and
b. provide technical support in
the implementation of the National Formulary policies
that have been established.
3. Implementation Team tasked to:
a. compile a list of drugs that will be included
in the National Formulary;
b. inventory and compile proposals
enter the list of drugs that will be included
in the National Formulary;
c. prepare a draft National Formulary;
and
d. carry out documentation, finalization
and reporting drafting
Formulary National.
4. The Review Team tasked to:
a. preparing a study evaluating the efficacy and
safety of drugs by asking for
consideration of the expert team of pharmacology and
clinical epidemiology; and
b. provide technical insert / scientific in
need evaluation team.
THIRD: The task of the Committee referred to in Dictum
Both came into force on January to
December 2015, except for the task team
evaluation until December 2016.
FOURTH: In the work of the Committee shall be
responsible and submit a report no later than 1
(one) month after the termination of their assignment to
the Minister of Health through the Director General of the
tasks and functions in the field of Pharmaceutical and Equipment
Health.
FIFTH: Any financing arising from the implementation of
the Committee's tasks charged to DIPA Directorate of
Pharmaceutical Services in 2015.
SIXTH: at the time of this decree, Decree
of the Minister of Health No. 228 / Menkes / SK / VI / 2013
on Formulation of National Formulary Committee
of the National 2013 revoked and declared no longer valid.
166
SIXTH: this decision becomes effective on the date
specified